Skip to main content
. Author manuscript; available in PMC: 2015 Apr 29.
Published in final edited form as: Sci Transl Med. 2014 Apr 16;6(232):232ra50. doi: 10.1126/scitranslmed.3008264

Table 2.

Subjects providing skin biopsies for mRNA analysis. None of the subjects had renal failure. Controls were healthy subjects (median age, 37 years; range, 30 to 63 years); 70% of the patients are female. PM, polymyositis overlap; EMS, eosinophilia-myaglia syndrome.

Study code Age (years) Sex Disease subtype Disease stage* mRSS
S1001 52 F dcSSc Late 24
SSc01LA 48 F dcSSc Early 21
SSc01BLA 46 F dcSSc Early 3
SSc02BLA 41 F dcSSc Early 21
SSc03LA 55 F lcSSc Early 11
SSc04LA 60 F lcSSc Late 4
SSc05RA 66 F dcSSc Early 9
SSc06BRA 53 F dcSSc Early 13
SSc07BLA 52 F dcSSc Early 17
SSc08BLA 34 F dcSSc Late 32
SSc10BLA 27 F dcSSc Late 26
SSc12 BLA 21 M dcSSc Early 15
SSc1002BLA 56 F dcSSc Late 34
SSc1004BLA 55 F dcSSc Early 19
SSc1066LA 26 F lcSSc Late 5
SSc1067LA 54 F dcSSc Late 13
SSc1080LA 48 F SSc/PM Early 20
SSc1096LA 45 F EMS Early 23
SSc1103BLA 30 F dcSSc Late 4
SSc1156BLA 50 F dcSSc Early 14
*

Early, <2 years from first non-Raynaud disease manifestation;late, >2 years from first non-Raynaud manifestation.